A prospective study to validate the diagnostic sensitivity of SOSE in EUS-TA using a 22-gauge Franseen needle for upper gastrointestinal subepithelial lesions of 10-19 mm.

A prospective study to validate the diagnostic sensitivity of SOSE in EUS-TA using a 22-gauge Franseen needle for upper gastrointestinal subepithelial lesions of 10-19 mm. - A prospective study to validate the diagnostic sensitivity of SOSE in EUS-TA using a 22-gauge Franseen needle for upper gastrointestinal subepithelial lesions of 10-19 mm.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050716

Enrollment

Registered

2023-05-01

Start date

2023-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal subepithelial lesion derived from proper muscle layer

Interventions

Performing EUS-TA with SOSE using a 22-gauge franseen needle needle

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 10-19mm upper gastrointestinal subepithelial lesions derived from proper muscle layer which are diagnosed from EUS and required EUS-TA for pathological diagnosis. 2. Providing written informed consent, and age =or >20

Exclusion criteria

Exclusion criteria: 1. bleeding disorders 2. severe mental disorders 3. pregnacy

Design outcomes

Primary

Measure	Time frame
Sensitivity of cutoff value for SOSE in EUS-TA	—

Countries

Japan

Contacts

Public ContactMasafumi Watanabe

Kitasato University School of Medicine Department of Gastroenterology

m.wata@kitasato-u.ac.jp81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026